www.loltestab.fora.pl
Just a simple test
FAQ
Search
Memberlist
Usergroups
Galleries
Register
Profile
Log in to check your private messages
Log in
www.loltestab.fora.pl Forum Index
->
Forum testowe
Post a reply
Username
Subject
Message body
Emoticons
View more Emoticons
Font colour:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
White
Black
Font size:
Tiny
Small
Normal
Large
Huge
Close Tags
Options
HTML is
OFF
BBCode
is
ON
Smilies are
ON
Disable BBCode in this post
Disable Smilies in this post
Confirmation code: *
All times are GMT + 2 Hours
Jump to:
Select a forum
Jakaś kategoria
----------------
Forum testowe
Topic review
Author
Message
cheapbag214s
Posted: Sun 2:55, 03 Nov 2013
Post subject: especially for unmet medical needs
India's Supreme Court declines Novartis patent request
MUMBAI, April 1 () -- India's Supreme Court Monday declined to grant patent protection to Glivec, a blood cancer drug made by Swiss pharmaceutical company Novartis AG.The company had been trying to obtain a patent in India for a newer version of Glivec, but the court said a substance used in the drug is already a known one and hence the company cannot seek a patent for the drug using that substance, the Press Trust of India news agency reported.Other foreign pharmaceutical companies seeking to enter India's growing market for drugs had been keenly awaiting the ruling.The PTI report said a monthlong supply of Glivec costs about 15 times that of the generic variety in India.Advocate Pratibha Singh, appearing for Indian drug firms Ranbaxy and Cipla, which had opposed Novartis' plea, said the judgment is a victory for Indian companies because they can now manufacture cheaper drugs as long as there is no patent over a medicine."Patents will now be granted only for genuine inventions and not on repetitive inventions. The Supreme Court said there was no new invention in the Novartis' drug," Singh said.She said foreign firms need not be concerned by the ruling because they would still get patents if they have genuine inventions, PTI reported.Novartis, in a news release, said the patent was denied despite global recognition of Glivec as a life-saving,[url=http://www.christianslouboutinsales.com]Christian Louboutin Outlet Online[/url], breakthrough drug for certain forms of cancer, with patents granted in about 40 countries including China, Russia and Taiwan."Novartis has never been granted an original patent for Glivec in India. We strongly believe that original innovation should be recognized in patents to encourage investment in medical innovation, especially for unmet medical needs," said Ranjit Shahani, managing director of Novartis India Ltd.The ruling "is a setback for patients that will hinder medical progress for diseases without effective treatment options," he said.
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2005 phpBB Group
Regulamin